Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients
Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients
05 Jan 2022

In patients with Kawasaki disease, every day that intravenous immunoglobulin (IVIG) treatment is delayed aggravates the risk of developing coronary artery aneurysms (CAA), a recent study has found.

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients
05 Jan 2022
COVID-19 vaccines promising in multiple myeloma patients
COVID-19 vaccines promising in multiple myeloma patients
05 Jan 2022
Abdominal adipose tissue radiodensity predicts survival after colorectal cancer
Abdominal adipose tissue radiodensity predicts survival after colorectal cancer
04 Jan 2022
Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
04 Jan 2022 bởiAudrey Abella

In women with hormone-receptor positive advanced breast cancer (HR+ aBC), the addition of the class I selective histone deacetylase (HDAC) inhibitor entinostat to exemestane appeared to be better than treatment with exemestane alone in terms of survival benefit, according to a phase III trial from China.

Entinostat-exemestane combo yields survival benefit for HR+ advanced BC
04 Jan 2022